Relationship and significance between anti-β2-glycoproteinI antibodies and platelet activation state in patients with ulcerative colitis

Table 1 Detection results of aβ₂GPI in patients among groups (A₄₉₂, mean ± SD)

Group	n	IgM	IgG
Active UC group	36	0.43 ± 0.13b	0.61 ± 0.13bd
Remittent UC group	20	0.38 ± 0.12b	0.50 ± 0.13b
Control group	25	0.20 ± 0.12	0.22 ± 0.14

^bP < 0.01 vs control group;

^dP < 0.01 vs remittent UC group.